Achieving smoking cessation in nicotine-dependent individuals

CNS Drugs

Volumn 8, Issue 1, 1997, Pages 12-20

  Mielke, Michelle M ^a,b   Jorenby, Douglas E ^a   Fiore, Michael C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLONIDINE; MECAMYLAMINE; NICOTINE; NICOTINE GUM;

ACUPUNCTURE; AEROSOL; ARTICLE; BEHAVIOR THERAPY; CHEWING GUM; CLINICAL TRIAL; DRUG DEPENDENCE; HEALTH CARE POLICY; HUMAN; HYPNOSIS; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; SMOKING CESSATION; SOCIAL SUPPORT; SUBSTITUTION THERAPY; TOBACCO; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030744992     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199708010-00002     Document Type: Article

References (28)

1. Centers for Disease Control. Reducing the health consequences of smoking: 25 years of progress - a report of the Surgeon General, 1989. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, 1989. DHHS publication No. (CDC) 89-8411
2. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull 1996; 52: 12-21
3. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical Practice Guideline No. 18. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996. AHCPR Publication No. 96-0692
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
5. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA 1995; 274: 1347-52
6. Jorenby DE, Keehn DS, Fiore MC. Comparative efficacy and tolerability of nicotine replacement therapies. CNS Drugs 1995; 3: 227-36
7. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271: 1940-7
8. Gourlay S. The pros and cons of transdermal nicotine therapy. Med J Aust 1994; 160: 152-9
9. Po ALW. Transdermal nicotine in smoking cessation: a meta-analysis. Eur J Clin Pharmacol 1993; 45: 519-28
10. Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-42
11. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994; 308: 21-6
12. Pierce JP, Gilpin E, Farkas AJ. Nicotine patch use in the general population: results from the 1993 California tobacco survey. J Natl Cancer Inst 1995; 87: 87-93
13. Lam W, Sze PC, Sacks HS, et al. Meta-analysis of randomised controlled trials of nicotine chewing gum. Lancet 1987; 2: 27-30
14. Hjalmarson A, Franzon M, Westin A, et al. Effect of nicotine nasal spray on smoking cessation: a randomized, placebo-controlled, double-blind study. Arch Intern Med 1994; 154: 2567-72
15. Sutherland G, Stapleton JA, Russell MAH, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340: 324-9
16. Schneider NG, Olmslead R, Mody FV, et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995; 90: 1671-82
17. McNeil Consumer Products Co. Nicotrol NS (nicotine nasal spray) package insert. Fort Washington (PA): McNeil Consumer Products Co., 1996
18. Schneider NG, Olmstead R, Nilsson F, et al. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 1996; 91: 1293-306
19. Leischow SJ, Nilsson F, Franzon M, et al. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav 1996; 20: 364-71
20. Tonnesen P, Norregaard J, Mikkelsen K, et al. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993; 269: 1268-71
21. Sachs DPL. Effectiveness of the 4mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Arch Intern Med 1995: 155: 1973-80
22. Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41-7
23. Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988; 259: 2863-6
24. Rose JE, Behm FM, Westman EC, et al. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 1994; 56: 86-99
25. Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking: a national perspective. JAMA 1990; 264: 1541-5
26. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464-9
27. Glassman AH, Heizer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264: 1546-9
28. Lichtenstein E, Hollis J. Patient referral to a smoking cessation program: who follows through? J Fam Pract 1992; 34: 739-44